VEGFA and hepatocellular carcinoma: Considering that VEGF levels are upregulated following RT treatment in HCC patients [100], it is rational to assess the benefits of anti-angiogenic and ICB therapy after RT because of their ability to enhance antitumor functions among HCC patients.